Last $9.96 USD
Change Today -0.50 / -4.78%
Volume 78.9K
BIOA On Other Exchanges
Symbol
Exchange
New York
EN Paris
As of 8:04 PM 04/23/14 All times are local (Market data is delayed by at least 15 minutes).

bioamber inc (BIOA) Snapshot

Open
$10.53
Previous Close
$10.46
Day High
$10.88
Day Low
$9.87
52 Week High
03/6/14 - $15.05
52 Week Low
09/13/13 - $3.96
Market Cap
184.9M
Average Volume 10 Days
52.4K
EPS TTM
$-1.86
Shares Outstanding
18.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for BIOAMBER INC (BIOA)

Related News

No related news articles were found.

bioamber inc (BIOA) Related Businessweek News

No Related Businessweek News Found

bioamber inc (BIOA) Details

BioAmber Inc., an industrial biotechnology company, produces and sells bio-succinic acid to customers in various chemical markets in the United States. Its proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into chemicals that are replacements for petroleum-derived chemicals. The company’s bio-succinic acid is used in various applications, including plasticizers, polyurethanes, personal care products, resins and coatings, de-icing and coolant solutions, fine chemicals, lubricants, and food additives, as well as anti-freeze solutions, coolants solvents, water treatment chemicals, laundry tablets and bath salts, artificial leather products, and foams made with recycled polyethylene terephthalate. Its product pipeline also includes bio-succinic acid derivatives, such as 1, 4 butanediol, gamma-butyrolactone, and succinic acid based polyesters. The company sells its products directly to its customers and commercial partners, as well as indirectly through distributor in the Asia-Pacific region. It has strategic relationships with various companies, including Mitsubishi Chemical Corporation for bio-succinic acid. The company was formerly known as DNP Green Technology, Inc. and changed its name to BioAmber Inc. in September 2010. BioAmber Inc. is headquartered in Montreal, Canada.

54 Employees
Last Reported Date: 03/28/14

bioamber inc (BIOA) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $390.2K
Chief Commercial Officer
Total Annual Compensation: $270.0K
Compensation as of Fiscal Year 2012.

bioamber inc (BIOA) Key Developments

BioAmber Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2013

BioAmber Inc. announced unaudited consolidated earnings results for the fourth quarter and year ended December 31, 2013. Revenue for the year ended December 31, 2013 increased 16% to $2.7 million as compared to $2.3 million for the year ended December 31, 2012. The increase in revenue was primarily due to higher volumes of Bio-SA sold, partially off-set by a decrease in the average selling price as the Company expanded its customer base and sold to certain customers who sought pricing closer to the selling prices they are offering for future Sarnia production. Gross profit in the year ended December 31, 2013 decreased to a loss of $24,000 compared to a profit of $545,000 in the year ended December 31, 2012. The reduced gross profit in 2013 was primarily due to the lower average selling price, which was partially offset by a 32% reduction in the unit cost of goods sold in 2013 relative to 2012. The Company recorded a net loss attributable to shareholders of $33.2 million, or $2.13 per basic share, for the year ended December 31, 2013, compared to $39.3 million, or $3.82 per basic share, for the year ended December 31, 2012. The Adjusted Net Loss Attributable to company Shareholders for the year ended December 31, 2013 was $33.3 million, or $2.14 per basic share, compared to an Adjusted net loss attributable to company shareholders of $35.1 million, or $3.40 per basic share, for the year ended December 31, 2012. Operating loss was $41.180 million against $39.109 million a year ago. Net cash used in operating activities was $27.525 million against $32.276 million a year ago. Acquisition of property and equipment was $12.788 million against $6.630 million a year ago. For the quarter, the company reported product sales of $0.439 million, operating loss of $7.810 million and net loss attributable to shareholders of $7.828 million or $0.42 per basic share compared to product sales of $0.831 million, operating loss of $9.166 million and net loss attributable to shareholders of $9.290 million or $0.90 per basic share a year ago period. Net cash used in operating activities was $4.815 million against $7.569 million a year ago. Acquisition of property and equipment was $8.181 million against $0.853 million a year ago. Adjusted Net Loss attributable to company shareholders was $8.388 million or $0.45 per basic share against $8.077 million or $0.78 per basic share a year ago.

BioAmber Inc. to Report Q4, 2013 Results on Mar 13, 2014

BioAmber Inc. announced that they will report Q4, 2013 results on Mar 13, 2014

BioAmber Inc., Q4 2013 Earnings Call, Mar 13, 2014

BioAmber Inc., Q4 2013 Earnings Call, Mar 13, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIOA:US $9.96 USD -0.50

BIOA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BIOA.
View Industry Companies
 

Industry Analysis

BIOA

Industry Average

Valuation BIOA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 72.5x
Price/Book 3.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 29.5x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOAMBER INC, please visit www.bio-amber.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.